Entrada Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Entrada Therapeutics, Inc.
CIK #0001689375
EDGAR Form CIK 2011 - 2026
10-K [0001689375]
10-Q [0001689375]
3 [0001689375]
4 [0001689375]
8-K [0001689375]
D [0001689375]
SC 13D [0001689375]
SC 13G [0001689375]
Form 13D/13G Filer Form 13D/13G Subject Filed
TCG Crossover GP I LLC Entrada Therapeutics Inc [2025-11-25]
Janus Henderson Group PLC Entrada Therapeutics Inc [2025-02-14]
BlackRock Inc Entrada Therapeutics Inc [2025-02-04]
Price T Rowe Associates Inc /MD/ Entrada Therapeutics Inc [2022-02-14]
Redmile Group LLC Entrada Therapeutics Inc [2022-02-14]
Roche Finance Ltd Entrada Therapeutics Inc [2022-02-14]
MRL Ventures Fund LLC Entrada Therapeutics Inc [2022-02-08]
Wellington Management Group LLP Entrada Therapeutics Inc [2022-02-04]
Baker Bros Advisors LP Entrada Therapeutics Inc [2021-12-16]
5AM Ventures V LP Entrada Therapeutics Inc [2021-11-12]
View All
Form 3/4/5 Subject 2011 - 2026
Entrada Therapeutics, Inc.
Radhakrishnan Maha
Parmar Kush
Kim Peter S
Chapman Gina
Thistle Mary
Zeiher Bernhardt G
Sethuraman Natarajan
Dowden Nathan J
Wentworth KORY James
View All
Terms | Privacy | Guide
tony@aum13f.com